Skip to main content

Position Paper: The Renin-Angiotensin-Aldosterone System for Blood Pressure Regulation and for Subdividing Patients to Reveal and Analyze Different Forms of Hypertension

  • Conference paper
Frontiers in Hypertension Research

Abstract

A sustaining or causal role for renin in essential hypertension has at least begun to gain credence along with the concept that essential hypertension is not a single clinical entity. Indeed, only recently has renin secretion been implicated in renovascular hypertension; renin measurements were not included even in the broad 1972 evaluation of renovascular hypertension formulated by the National Cooperative Study Group (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Vaughan ED Jr, Laragh JH (1975) New concepts of the renin system and of vasoconstriction-volume mechanisms: Diagnosis and treatment of renovascular and renal hypertension. Urol Clin North Am 2: 237–257

    PubMed  Google Scholar 

  2. Laragh JH, Ulick S, Januszewicz V, Demin QB, Kelly WG, Lieberman S (1960) Aldosterone secretion and primary and malignant hypertension. J Clin Invest 39: 1091–1106

    Article  PubMed  CAS  Google Scholar 

  3. Laragh JH, Angers M, Kelly WG, Lieberman S (1960) Hypotensive agents and pressor substances: The effect of epinephrine, norepinephrine, angiotensin II and others on the secretory rate of aldosterone in man. JAMA 174: 234–240

    PubMed  CAS  Google Scholar 

  4. Laragh JH (1960) The role of aldosterone in man: Evidence for regulation of electrolyte balance and arterial pressure by renal-adrenal system which may be involved in malignant hypertension. JAMA 174: 293–295

    PubMed  CAS  Google Scholar 

  5. Laragh JH, Sealey JE (1973) The renin-angiotensin- aldosterone hormonal system and regulation of sodium, potassium, and blood pressure homeostasis. In: Orloff J, Berliner RW (eds) American Physiological Society (Handbook of physiology—renal physiology). Waverly Press, Baltimore, pp 831–908

    Google Scholar 

  6. Sealey JE, Laragh JH (1974) A proposed cybernetic system for sodium and potassium homeostasis: Coordination of aldosterone and intrarenal physical factors. Kidney Int 6: 281–290

    Article  PubMed  CAS  Google Scholar 

  7. Bühler FR, Laragh JH, Baer L, Vaughan ED Jr, Brunner HR (1972) Propranolol inhibition of renin secretion: A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med 287: 1209–1214

    Article  PubMed  Google Scholar 

  8. Laragh JH, Baer L, Brunner HR, Bühler FR, Sealey JE, Vaughan ED Jr (1972) Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med 52: 633–652

    Article  PubMed  CAS  Google Scholar 

  9. Sealey JE, Laragh JH (1977) How to do a plasma renin assay. Cardiovasc Med 2: 1079–1092

    CAS  Google Scholar 

  10. Sealey JE, Laragh JH (1975) “Prorenin” in human plasma? Methodological and physiological implications. Circ Res 36, 37(Suppl I): I-10–I-16

    Google Scholar 

  11. Ryan MP, Weinberger MH (1980) Effect of sulphy-dryl reagents on the enzymatic activity of human renin: Implications for renin assay. Clin Chim Acta106: 135–143

    Article  PubMed  CAS  Google Scholar 

  12. Laragh JH, Sealey JE, Ledingham JGG, Newton MA (1967) Oral contraceptives: Renin, aldosterone and high blood pressure. JAMA 201: 918–922

    Article  PubMed  CAS  Google Scholar 

  13. Ames RP, Borkowski AJ, Sicinski AM, Laragh JH (1965) Prolonged infusions of angiotensin II and norepinephrine and blood pressure, electrolyte balance, aldosterone and Cortisol secretion in normal man and in cirrhosis with ascites. J Clin Invest 44: 1171–1186

    Article  PubMed  CAS  Google Scholar 

  14. Brunner HR, Laragh JH, Baer L, Newton MA, Goodwin FT, Krakoff LR, Bard RH, Buhler FR (1972) Essential hypertension: Renin and aldosterone, heart attack and stroke. N Engl J Med 286: 441–449

    Article  PubMed  CAS  Google Scholar 

  15. Brunner HR, Sealey JE, Laragh JH (1973) Renin as a risk factor in essential hypertension: More evidence. Am J Med 55: 295–302

    Article  PubMed  CAS  Google Scholar 

  16. Orjavik OS, Aas M, Fauchold P, et al (1975) Renin secreting tumors with severe hypertension. Acta Med Scand 197: 329–336

    Article  PubMed  CAS  Google Scholar 

  17. Perera GN, Haelig AW (1952) Clinical characteristics of hypertension associated with unilateral renal disease. Circulation 6: 349

    Google Scholar 

  18. Davis BA, Crook JE, Vestal RE, Oates JA (1979) Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. N Engl J Med 301: 1273–1276

    Article  PubMed  CAS  Google Scholar 

  19. Gavras H, Brunner HR, Laragh JH (1974) Renin and aldosterone and the pathogenesis of hypertensive vascular damage. Prog Cardiovasc Dis 17: 39–49

    Article  PubMed  CAS  Google Scholar 

  20. Laragh JH (1978) Renin as a predictor of hypertensive complications: Discussion. Ann NY Acad Sci 304: 165–177

    Article  PubMed  CAS  Google Scholar 

  21. Keim HJ, Drayer JIM, Case DB, Lopez-Ovejero J A, Wallace JM, Laragh JH (1976) A role for renin in rebound hypertension and encephalopathy after infusion of sar1-ala8-angiotensin II. N Engl J Med 295: 1175–1177

    Article  PubMed  CAS  Google Scholar 

  22. Laragh JH (1978) The renin system in high blood pressure, from disbelief to reality: Converting enzyme blockade for analysis and treatment. Prog Cardiovasc Dis 21: 159–166

    Article  PubMed  CAS  Google Scholar 

  23. Amery A, Lijnen P, Fagard R, Reybrouck T (1976) Plasma renin activity vs. concentration. N Engl J Med 295: 1198C

    Google Scholar 

  24. Brunner HR, Gavras H, Laragh JH (1973) Angiotensin II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood pressure. Lancet 2: 1045–1048

    Article  PubMed  CAS  Google Scholar 

  25. Case DB, Wallace JM, Keim HJ, Sealey JE, Laragh JH (1976) Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II for evaluating the renin and sodium factors in hypertensive patients. Am J Med 60: 825–836

    Article  PubMed  CAS  Google Scholar 

  26. Case DB, Wallace JM, Keim HJ, Weber MA, Drayer JIM, White RP, Sealey JE, Laragh JH (1976) Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin. Am J Med 61: 790–796

    Article  PubMed  CAS  Google Scholar 

  27. Gavras H, Brunner HR, Laragh JH, Sealey JE, Gavras I, Vukovitch RA (1974) An angiotensin converting enzyme inhibitor to identify and treat vasoconstriction and volume factors in hypertensive patients. New Engl J Med 291: 817–821

    Article  PubMed  CAS  Google Scholar 

  28. Case DB, Wallace JM, Keim HJ, Weber MA, Sealey JE, Laragh JH (1977) Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med 296: 641–646

    Article  PubMed  CAS  Google Scholar 

  29. Case DB, Atlas SA, Laragh JH, Sealey JE, Sullivan PA, McKinstry DN (1978) Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog Cardiovasc Dis 21: 195–206

    Article  PubMed  CAS  Google Scholar 

  30. Brunner HR, Gavras H, Laragh JH, KeenanR (1974) Hypertension in man: Exposure of the renin and sodium components using angiotensin II blockade. Circ Res 34, 35(Suppl. I): I-35–I-45

    Google Scholar 

  31. Brunner HR, Kirshman JD, Sealey JE, Laragh JH(1971) Hypertension of renal origin: Evidence for two different mechanisms. Science 174: 1344–1346

    Article  PubMed  CAS  Google Scholar 

  32. Gavras H, Brunner HR, Vaughan ED Jr, Laragh JH (1973) Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and nor-motensive rats. Science 180: 1369–1372

    Article  PubMed  CAS  Google Scholar 

  33. Laragh JH (1973) Vasoconstriction-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profiles. Am J Med 55: 261–274

    Article  PubMed  CAS  Google Scholar 

  34. Tarazi RC, Dustan HP (1972) Beta adrenergic blockade in hypertension. Am J Cardiol 29: 633

    Article  PubMed  CAS  Google Scholar 

  35. Laragh JH, Letcher RL, Pickering TG (1979) Renin profiling for modern diagnosis and treatment of hypertension. JAMA 241: 151–156

    Article  PubMed  CAS  Google Scholar 

  36. Esler M, Randall O, Bennett J, et al (1976) Suppression of sympathetic nervous function in low-renin essential hypertension. Lancet 2: 115–118

    Article  PubMed  CAS  Google Scholar 

  37. Weidmann P, Hirsch D, Beretta-Piccol C, et al (1977) Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension. Am J Med 62: 209–218

    Article  PubMed  CAS  Google Scholar 

  38. Laragh JH (1976) Modern system for treating high blood pressure based on renin profiling and vasoconstriction volume analysis: A primary role for beta blocking drugs such as propranolol. Am J Med 61: 797–810

    Article  PubMed  CAS  Google Scholar 

  39. Laragh JH, Sealey JE (1977) Renin-sodium profiling: Why, how and when in clinical practice. Cardiovasc Med 2: 1053–1075

    CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag New York Inc.

About this paper

Cite this paper

Laragh, J.H. (1981). Position Paper: The Renin-Angiotensin-Aldosterone System for Blood Pressure Regulation and for Subdividing Patients to Reveal and Analyze Different Forms of Hypertension. In: Laragh, J.H., Bühler, F.R., Seldin, D.W. (eds) Frontiers in Hypertension Research. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5899-5_34

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-5899-5_34

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-5901-5

  • Online ISBN: 978-1-4612-5899-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics